Should you avoid OPKO Health Inc (OPK) stock?
Apr 18, 2022 · Opko Health, Inc. NYSEMkt Updated Apr 18, 2022 11:59 PM OPK 3.17 0.17 (5.09%). Post-Market 0.03 (0.95%)
How can I get the latest news and ratings for OPK?
Apr 14, 2022 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas top-performing Wall Street analysts.
Is OPKO Health burning through cash?
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know OPKO Health (OPK) closed the most recent trading day at $3.51, moving …
How did OPKO's cash position fluctuate in Q4?
Apr 20, 2022 · The Opko Health Inc stock price fell by -0.31% on the last day (Wednesday, 20th Apr 2022) from $3.21 to $3.20. During the day the stock fluctuated 2.83% from a day low at $3.18 to a day high of $3.27. The price has fallen in 7 of the last 10 days and is down by -8.31% for this period. Volume fell on the last day along with the stock, which is actually a good sign as …
Why is OPK going down?
Revenues from Services amounted to $507 million in the reported quarter, up 196.8% year over year driven by COVID-19 testing volume. However, decline in revenues in the company's bases testing business, which represents the negative impact of the COVID-19 pandemic, partially offset the upside.May 28, 2021
Is OPK stock a buy?
According to the issued ratings of 3 analysts in the last year, the consensus rating for OPKO Health stock is Buy based on the current 1 hold rating and 2 buy ratings for OPK.
Will OPK stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.75, with a high estimate of 8.50 and a low estimate of 5.50. The median estimate represents a +108.33% increase from the last price of 3.24.
What is OPK new price target?
Stock Price Target OPKHigh$8.50Median$6.75Low$5.50Average$6.88Current Price$2.93
Is OPK a good stock to buy 2022?
Is OPKO HEALTH Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPK) stock is to Buy OPK stock.
Does OPK stock pay dividends?
OPK does not currently pay a dividend.
When did Opk go public?
The Company expects its common stock will begin trading on the NASDAQ Global Select Market (“NASDAQ”) on June 24, 2016, and its shares will continue to trade under the ticker symbol “OPK.”Jun 13, 2016
What does OPKO Health make?
pharmaceuticalsOPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
OPKO Health Media Sentiment
Media Coverage
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
OPKO Health (NASDAQ OPK) News Headlines Today
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
OPKO Health's (OPK) Arm Boosts Prenatal Screening With Buyout
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
OPKO Health's, Inc. (NASDAQ:OPK) CEO is on a Buying Spree Before the US Drug Approval Decision
OPKO Health's (OPK) BioReference's acquisition to expand its NIPS offerings and thereby enhance prenatal screening.
Midday Market Update: Why Are Stocks Down Today?
OPKO Health, Inc. (NASDAQ:OPK) a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Their CEO has been continuously buying shares, and we were curious as to why that might be.
OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down
The stock market isn’t doing so hot on Friday as market worries continue to weigh on investors in our midday update. Source: Shutterstock There’s no getting around the fact that fears of the delta variant of the novel coronavirus are spreading. In addition to that, investors also have concerns when it comes to inflation and the rest of the market.
Opko Health (OPK) Q2 2021 Earnings Call Transcript
OPKO Health's (OPK) second-quarter results benefit from strength in both its reportable segments.
OPKO Health (OPK) Reports Q2 Loss, Misses Revenue Estimates
Image source: The Motley Fool. Opko Health (NASDAQ: OPK)Q2 2021 Earnings CallJul 29, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, ladies and gentlemen, and welcome to the OPKO Health second-quarter 2021 financial results conference call.
Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline
OPKO Health (OPK) delivered earnings and revenue surprises of -250.00% and -3.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Signals & Forecast
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Opko Health Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is Opko Health Inc stock A Buy?
Opko Health Inc finds support from accumulated volume at $3.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Component Grades
Opko Health Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
OPK POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
OPK Stock Summary
OPK scores best on the Value dimension, with a Value rank ahead of 76.1% of US stocks.
OPK Valuation Summary
Equity multiplier, or assets relative to shareholders' equity, comes in at 1.45 for Opko Health Inc; that's greater than it is for just 21.8% of US stocks.
OPK's Quality Factors
OPK's EV/EBIT ratio is 26; this is 11.26% lower than that of the median Healthcare stock.
Latest OPK News From Around the Web
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
Continue Researching OPK
Below are the latest news stories about Opko Health Inc that investors may wish to consider to help them evaluate OPK as an investment opportunity.
Who is Todd Eb?
Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:
Is Opko Health burning through cash?
In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn. Follow @ebcapital